Efficacy and safety of subcutaneous guselkumab induction therapy in participants with moderately to severely active ulcerative colitis (ASTRO): a double-blind, treat-through, randomised, placebo-controlled, phase 3 trial [0.03%]
克唑替尼治疗ROS1阳性晚期非小细胞肺癌患者的疗效和安全性：一项开放性、多中心的II期研究
Millie Long,Jessica R Allegretti,Silvio Danese et al.
Millie Long et al.
Background: Approved IL-23p19 subunit inhibitors, including guselkumab, require intravenous induction dosing in patients with ulcerative colitis. We aimed to evaluate the efficacy and safety of subcutaneous guselkumab ind...
Chronic liver disease and hepatology care in transgender and gender diverse populations [0.03%]
慢性肝病与性别多样人群的肝脏护理
Thanh N Nguyen,Whitney E Jackson,Nitzan C Roth et al.
Thanh N Nguyen et al.
Transgender and gender diverse (trans) people experience unique minority stressors related to their gender identity, along with additional psychosocial and systemic stressors that contribute to health disparities. Many risk factors for chro...
Samantha Conley,Kendra J Kamp,Sunanda V Kane
Samantha Conley
Definitions, diagnosis, management, and outcomes of upper gastrointestinal Crohn's disease: an international, expert RAND/UCLA appropriateness study [0.03%]
关于克罗恩病的定义、诊断、治疗和结局的国际专家RAND/UCLA适宜性研究
Nathaniel A Cohen,Dominik Bettenworth,Neta Sror et al.
Nathaniel A Cohen et al.
Patients with Crohn's disease can have isolated or co-existent upper gastrointestinal involvement, but this is an understudied clinical manifestation. There are neither standardised definitions nor diagnostic or management recommendations t...
Alexandra Damasio Todescatto,Paulo Gustavo Kotze
Alexandra Damasio Todescatto
Appendicectomy versus switching to a JAK inhibitor in inducing remission in patients with active ulcerative colitis after biologic therapy failure (COSTA): 1-year results of a multicentre, prospective, cohort study [0.03%]
在生物制剂治疗失败的活动性溃疡性结肠炎患者中，回切术与换用JAK抑制剂诱导缓解的比较（COSTA）：多中心前瞻性队列研究的一年结果
Eva Visser,Maud A Reijntjes,Lianne Heuthorst et al.
Eva Visser et al.
Background: Although retrospective and limited prospective observational studies have suggested a potential benefit of appendicectomy in therapy-refractory ulcerative colitis, its effectiveness compared with advanced medi...
Correction to Lancet Gastroenterol Hepatol 2025; 10: 431-41 [0.03%]
肠道微生物组与异基因造血细胞移植后移植物抗宿主病复发和感染的关联：一项队列研究纠正原文献标题为《Correlation of gut microbiome with graft-versus-host disease relapse and infection after allogeneic haemopoietic cell transplantation: a cohort study》发表于《Lancet Gastroenterol Hepatol 2025; 10: 431-41》中的错误
The label of a diagnosis [0.03%]
诊断的标签
Cheryl Reeves
Cheryl Reeves
Clinical remission in ulcerative colitis: restoring precision in trial terminology [0.03%]
溃疡性结肠炎临床缓解：在试验术语中恢复精准性
Sailish Honap,Vipul Jairath,Fernando Magro et al.
Sailish Honap et al.